Related references
Note: Only part of the references are listed.Targeting mTOR and Glycolysis in HER2-Positive Breast Cancer
Ryan W. Holloway et al.
CANCERS (2021)
The emerging role of targeting cancer metabolism for cancer therapy
Pegah Farhadi et al.
TUMOR BIOLOGY (2020)
Consideration of Ketogenic Metabolic Therapy as a Complementary or Alternative Approach for Managing Breast Cancer
Thomas N. Seyfried et al.
FRONTIERS IN NUTRITION (2020)
Cancer cells change their glucose metabolism to overcome increased ROS: One step from cancer cell to cancer stem cell?
Zahra Ghanbari Movahed et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
SGLT1 is required for the survival of triple-negative breast cancer cells via potentiation of EGFR activity
Huiquan Liu et al.
MOLECULAR ONCOLOGY (2019)
Role of mitochondria in rescuing glycolytically inhibited subpopulation of triple negative but not hormone-responsive breast cancer cells
Asmaa Reda et al.
SCIENTIFIC REPORTS (2019)
Metabolic reprogramming in breast cancer results in distinct mitochondrial bioenergetics between luminal and basal subtypes
Paola Lunetti et al.
FEBS JOURNAL (2019)
A systematic flux analysis approach to identify metabolic vulnerabilities in human breast cancer cell lines
Sheree D. Martin et al.
CANCER & METABOLISM (2019)
2-Deoxy-D-Glucose inhibits aggressive triple-negative breast cancer cells by targeting glycolysis and the cancer stem cell phenotype
Sadhbh O'Neill et al.
SCIENTIFIC REPORTS (2019)
Glucose transporters in cancer - from tumor cells to the tumor microenvironment
Pierre-Benoit Ancey et al.
FEBS JOURNAL (2018)
The relevance of tyrosine kinase inhibitors for global metabolic pathways in cancer
Michaela Poliakova et al.
MOLECULAR CANCER (2018)
Elucidating the Metabolic Plasticity of Cancer: Mitochondrial Reprogramming and Hybrid Metabolic States
Dongya Jia et al.
CELLS (2018)
Sodium-glucose cotransporters: new targets of cancer therapy?
Ivana Vrhovac Madunic et al.
ARHIV ZA HIGIJENU RADA I TOKSIKOLOGIJU-ARCHIVES OF INDUSTRIAL HYGIENE AND TOXICOLOGY (2018)
Stable Isotope-Resolved Metabolomic Differences between Hormone-Responsive and Triple-Negative Breast Cancer Cell Lines
Jason H. Winnike et al.
INTERNATIONAL JOURNAL OF BREAST CANCER (2018)
A Metabolomics Study of BPTES Altered Metabolism in Human Breast Cancer Cell Lines
G. A. Nagana Gowda et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2018)
Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping
Xiaofeng Dai et al.
JOURNAL OF CANCER (2017)
Intratumor Heterogeneity in Primary Kidney Cancer Revealed by Metabolic Profiling of Multiple Spatially Separated Samples within Tumors
Takatsugu Okegawa et al.
EBIOMEDICINE (2017)
Heterogeneity in Cancer Metabolism: New Concepts in an Old Field
Geraldine Gentric et al.
ANTIOXIDANTS & REDOX SIGNALING (2017)
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC-derived cardiomyocytes
Brian M. Necela et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2017)
Understanding the Intersections between Metabolism and Cancer Biology
Matthew G. Vander Heiden et al.
CELL (2017)
Glycolysis inhibition as a cancer treatment and its role in an anti-tumour immune response
Kheshwant S. Gill et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2016)
TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer
Ying-Hui Ko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences
Delisha A. Stewart et al.
JOURNAL OF PROTEOME RESEARCH (2016)
Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition
Marco Sciacovelli et al.
NATURE (2016)
Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
Roman Camarda et al.
NATURE MEDICINE (2016)
The Warburg Effect: How Does it Benefit Cancer Cells?
Maria V. Liberti et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Comparative metabolic and lipidomic profiling of human breast cancer cells with different metastatic potentials
Hye-Youn Kim et al.
ONCOTARGET (2016)
Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer
Jun Hyoung Park et al.
CELL REPORTS (2016)
Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes
Xiaofeng Dai et al.
JOURNAL OF CANCER (2016)
Fundamentals of cancer metabolism
Ralph J. DeBerardinis et al.
SCIENCE ADVANCES (2016)
A comparative study of protein patterns of human estrogen receptor positive (MCF-7) and negative (MDA-MB-231) breast cancer cell lines
Dana Flodrova et al.
GENERAL PHYSIOLOGY AND BIOPHYSICS (2016)
Metabolome analysis via comprehensive two-dimensional liquid chromatography: identification of modified nucleosides from RNA metabolism
Lucas Willmann et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2015)
Bioenergetic differences between MCF-7 and T47D breast cancer cells and their regulation by oestradiol and tamoxifen
Brandie N. Radde et al.
BIOCHEMICAL JOURNAL (2015)
Combined Label-Free Quantitative Proteomics and microRNA Expression Analysis of Breast Cancer Unravel Molecular Differences with Clinical Implications
Angelo Gamez-Pozo et al.
CANCER RESEARCH (2015)
Tumors and Mitochondrial Respiration: A Neglected Connection
Andrea Viale et al.
CANCER RESEARCH (2015)
MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells
Patricia Sancho et al.
CELL METABOLISM (2015)
PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer
Fanny Dupuy et al.
CELL METABOLISM (2015)
Metabolic profiling of breast cancer: Differences in central metabolism between subtypes of breast cancer cell lines
Lucas Willmann et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2015)
Metabolic differences in breast cancer stem cells and differentiated progeny
Erina Vlashi et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Regulation of HER2 Oncogene Transcription by a Multifunctional Coactivator/Corepressor Complex
Jason P. Garee et al.
MOLECULAR ENDOCRINOLOGY (2014)
The pentose phosphate pathway and cancer
Krushna C. Patra et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment
D. Ciavardelli et al.
CELL DEATH & DISEASE (2014)
Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential
Helene Pelicano et al.
BREAST CANCER RESEARCH (2014)
Comparative proteome profiling of breast tumor cell lines by gel electrophoresis and mass spectrometry reveals an epithelial mesenchymal transition associated protein signature
Daniele Vergara et al.
MOLECULAR BIOSYSTEMS (2013)
Plasma Metabolomic Profiles in Breast Cancer Patients and Healthy Controls: By Race and Tumor Receptor Subtypes
Jie Shen et al.
TRANSLATIONAL ONCOLOGY (2013)
miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs
Muhammad Riaz et al.
BREAST CANCER RESEARCH (2013)
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Patrick S. Ward et al.
CANCER CELL (2012)
Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells
Anne Le et al.
CELL METABOLISM (2012)
Glucose transporters in cancer metabolism
Kehinde Adekola et al.
CURRENT OPINION IN ONCOLOGY (2012)
The pentose phosphate pathway: An antioxidant defense and a crossroad in tumor cell fate
Chiara Riganti et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Publication of Tumor Marker Research Results: The Necessity for Complete and Transparent Reporting
Lisa M. McShane et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Integration of Metabolomics and Expression of Glycerol-3-phosphate Acyltransferase (GPAM) in Breast Cancer-Link to Patient Survival, Hormone Receptor Status, and Metabolic Profiling
Scarlet F. Brockmoeller et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Quantitative Analysis of Energy Metabolic Pathways in MCF-7 Breast Cancer Cells by Selected Reaction Monitoring Assay
Andrei P. Drabovich et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Basal-like Breast Cancer Cells Induce Phenotypic and Genomic Changes in Macrophages
Delisha A. Stewart et al.
MOLECULAR CANCER RESEARCH (2012)
Higher Population-Based Incidence Rates of Triple-Negative Breast Cancer Among Young African-American Women Implications for Breast Cancer Screening Recommendations
Kathryn C. Amirikia et al.
CANCER (2011)
Overcoming Trastuzumab Resistance in Breast Cancer by Targeting Dysregulated Glucose Metabolism
Yuhua Zhao et al.
CANCER RESEARCH (2011)
Metabolic Profiling of Hypoxic Cells Revealed a Catabolic Signature Required for Cell Survival
Christian Frezza et al.
PLOS ONE (2011)
1H NMR metabolomics combined with gene expression analysis for the determination of major metabolic differences between subtypes of breast cell lines
Miroslava Cuperlovic-Culf et al.
CHEMICAL SCIENCE (2011)
Glutamine Synthetase Is a Genetic Determinant of Cell Type-Specific Glutamine Independence in Breast Epithelia
Hsiu-Ni Kung et al.
PLOS GENETICS (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes
Michael L. Gatza et al.
BREAST CANCER RESEARCH (2011)
Histological, molecular and functional subtypes of breast cancers
Gautam K. Malhotra et al.
CANCER BIOLOGY & THERAPY (2010)
Differential expression of phosphofructokinase-1 isoforms correlates with the glycolytic efficiency of breast cancer cells
Patricia Zancan et al.
MOLECULAR GENETICS AND METABOLISM (2010)
Tamoxifen decreases extracellular TGF-beta 1 secreted from breast cancer cells - A post-translational regulation involving matrix metalloproteinase activity
Ulrika W. Nilsson et al.
EXPERIMENTAL CELL RESEARCH (2009)
Targeting of cancer energy metabolism
Sara Rodriguez-Enriquez et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2009)
Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth
Y. H. Zhao et al.
ONCOGENE (2009)
Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery
Jessica Kao et al.
PLOS ONE (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters
Sandip Basu et al.
CANCER (2008)
Intratumoral metabolic heterogeneity of cervical cancer
Elizabeth A. Kidd et al.
CLINICAL CANCER RESEARCH (2008)
Metabolic regulation by lactate
Mauro Sola-Penna
IUBMB LIFE (2008)
Triple-negative breast cancer: therapeutic options
Susan Cleator et al.
LANCET ONCOLOGY (2007)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
Succinate dehydrogenase and fumarate hydratase:: linking mitochondrial dysfunction and cancer
A. King et al.
ONCOGENE (2006)
Gene expression profiling of breast cell lines identifies potential new basal markers
E Charafe-Jauffret et al.
ONCOGENE (2006)
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
I Papandreou et al.
CELL METABOLISM (2006)
Radial compression of microtubules and the mechanism of action of taxol and associated proteins
DJ Needleman et al.
BIOPHYSICAL JOURNAL (2005)
Lactate in solid malignant tumors: Potential basis of a metabolic classification in clinical oncology
S Walenta et al.
CURRENT MEDICINAL CHEMISTRY (2004)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
Breast cell invasive potential relates to the myoepithelial phenotype
LA Gordon et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Comparison of p53 mutational status with mRNA and protein expression in a panel of 24 human breast carcinoma cell lines
N Concin et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Share Paper
